Advanced search
Publication Cover
Pharmacogenomics Volume 8, 2007 - Issue 1
Submit an article Journal homepage
565
Views
0
CrossRef citations to date
0
Altmetric
Research Report

Ethnicity-Related Polymorphisms and Haplotypes in the Human ABCB1 Gene

Chava Kimchi-Sarfaty1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected];2 Food and Drug Administration, Current address: Center for Biologics Evaluation and Research, 29 Lincoln Drive, Room 316, BethesdaMD20892, USA. Tel: +1 301 827 0039; Fax: +1 301 402 2780;View further author information
,
Andrew H Marple1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected]View further author information
,
Shiri Shinar1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected]View further author information
,
Avraham M Kimchi3 National Institutes of Health, National Center of Bioinformatics, Bethesda, MD20892–4254, USA.View further author information
,
David Scavo1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected]View further author information
,
M Isabella Roma1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected]View further author information
,
In-Wha Kim1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected]View further author information
,
Adam Jones1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected]View further author information
,
Mili Arora1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected]View further author information
,
John Gribar1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected]View further author information
,
David Gurwitz4 Tel-Aviv University, National Laboratory for the Genetics of Israeli Populations, Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel-Aviv69978, Israel. Tel: +972 3640 7611; Fax: +972 3640 7611;View further author information
&
Michael M Gottesman1 National Institutes of Health, Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, Bethesda, MD20892–4254, USA. Tel: +1 301 496 1530; Fax: +1 301 402 0450; [email protected]View further author information
 show all
Pages 29-39 | Published online: 22 Dec 2006

Bibliography

  • Borst P , ElferinkRO: Mammalian ABC transporters in health and disease.Annu. Rev. Biochem.71, 537–592 (2002).
  • Gottesman MM : Mechanisms of cancer drug resistance.Annu. Rev. Med.53, 615–627 (2002).
  • Mayer U , WagenaarE, BeijnenJH et al.: Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.Br. J. Pharmacol.119(5), 1038–1044 (1996).
  • Lee CG , GottesmanMM, CardarelliCO et al.: HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry37(11), 3594–3601 (1998).
  • Bogman K , PeyerAK, TorokM, KustersE, and Drewe J: HMG-CoA reductase inhibitors and P-glycoprotein modulation. Br. J. Pharmacol.132(6), 1183–1192 (2001).
  • Chiou WL , ChungSM, WuTC, MaC: A comprehensive account on the role of efflux transporters in the gastrointestinal absorption of 13 commonly used substrate drugs in humans.Int. J. Clin. Pharmacol. Ther.39(3), 93–101 (2001).
  • Venter JC , AdamsMD, MyersEW et al.: The sequence of the human genome.Science291(5507), 1304–1351 (2001).
  • Buckland PR : The importance and identification of regulatory polymorphisms and their mechanisms of action.Biochim. Biophys. Acta1762(1), 17–28 (2006).
  • Hoffmeyer S , BurkO, von Richter O et al.: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA97(7), 3473–3478 (2000).
  • Brinkmann U , RootsI, EichelbaumM: Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy.Drug Discov. Today6(16), 835–839 (2001).
  • Saito S , IidaA, SekineA et al.: Three hundred twenty-six genetic variations in genes encoding nine members of ATP-binding cassette, subfamily B (ABCB/MDR/TAP), in the Japanese population.J. Hum. Genet.47(1), 38–50 (2002).
  • Evans WE , McLeodHL: Pharmacogenomics – drug disposition, drug targets, and side effects.N. Engl. J. Med.348(6), 538–549 (2003).
  • Schwab M , EichelbaumM, FrommMF: Genetic polymorphisms of the human MDR1 drug transporter.Annu. Rev. Pharmacol. Toxicol.43, 285–307 (2003).
  • Kim RB , LeakeBF, ChooEF et al.: Identification of functionally variant MDR1 alleles among European Americans and African Americans.Clin. Pharmacol. Ther.70(2), 189–199 (2001).
  • Owen A , GoldringC, MorganP, Chadwick D, Park BK, Pirmohamed M: Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver. Br. J. Clin. Pharmacol.59(3), 365–370 (2005).
  • Behar DM , HammerMF, GarriganD et al.: MtDNA evidence for a genetic bottleneck in the early history of the Ashkenazi Jewish population.Eur. J. Hum. Genet.12(5), 355–364 (2004).
  • Behar DM , MetspaluE, KivisildT et al.: The matrilineal ancestry of Ashkenazi Jewry: portrait of a recent founder event.Am. J. Hum. Genet.78(3), 487–497 (2006).
  • Slatkin M : A population-genetic test of founder effects and implications for Ashkenazi Jewish diseases.Am. J. Hum. Genet.75(2), 282–293 (2004).
  • Gershoni-Baruch R , ShinawiM, LeahK, BadarnahK, BrikR: Familial Mediterranean fever: prevalence, penetrance and genetic drift.Eur. J. Hum. Genet.9(8), 634–637 (2001).
  • King MC , MarksJH, MandellJB: Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.Science302(5645), 643–646 (2003).
  • Aharon-Peretz J , RosenbaumH, Gershoni-BaruchR: Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.N. Engl. J. Med.351(19), 1972–1977 (2004).
  • Tukel T , ShalataA, PresentD et al.: Crohn disease: frequency and nature of CARD15 mutations in Ashkenazi and Sephardi/Oriental Jewish families.Am. J. Hum. Genet.74(4), 623–636 (2004).
  • Ostrovsky O , NaglerA, KorostishevskyM, GazitE, GalskiH: Genotype and allele frequencies of C3435T polymorphism of the MDR1 gene in various Jewish populations of Israel.Ther. Drug Monit.26(6), 679–684 (2004).
  • Kroetz DL , Pauli-MagnusC, HodgesLM et al.: Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics13(8), 481–494 (2003).
  • Johne A , KopkeK, GerloffT et al.: Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.Clin. Pharmacol. Ther.72(5), 584–594 (2002).
  • Potocnik U , FerkoljI, GlavacD, DeanM: Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis.Genes Immun.5(7), 530–539 (2004).
  • Zhao H , PfeifferR, GailMH: Haplotype analysis in population genetics and association studies.Pharmacogenomics4(2), 171–178 (2003).
  • Stephens M , SmithNJ, DonnellyP: A new statistical method for haplotype reconstruction from population data.Am. J. Hum. Genet.68(4), 978–989 (2001).
  • Stephens M , DonnellyP: A comparison of bayesian methods for haplotype reconstruction from population genotype data.Am. J. Hum. Genet.73(5), 1162–1169 (2003).
  • Ambudkar SV , Kimchi-SarfatyC, Sauna ZE, Gottesman MM: P-glycoprotein: from genomics to mechanism. Oncogene22(47), 7468–7485 (2003).
  • Asano T , TakahashiKA, FujiokaM et al.: ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation.Pharmacogenetics13(11), 675–682 (2003).
  • Kurzawski M , DrozdzikM, SuchyJ et al.: Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients.Eur. J. Clin. Pharmacol.61(5–6), 389–394 (2005).
  • Tan EK , ChanDK, NgPW et al.: Effect of MDR1 haplotype on risk of Parkinson disease.Arch. Neurol.62(3), 460–464 (2005).
  • Goreva OB , GrishanovaAY, MukhinOV, DomnikovaNP, LyakhovichVV: Possible prediction of the efficiency of chemotherapy in patients with lymphoproliferative diseases based on MDR1 gene G2677T and C3435T polymorphisms.Bull. Exp. Biol. Med.136(2), 183–185 (2003).
  • Zhu D , Taguchi-NakamuraH, GotoM et al.: Influence of single-nucleotide polymorphisms in the multidrug resistance-1 gene on the cellular export of nelfinavir and its clinical implication for highly active antiretroviral therapy. Antivir. Ther.9(6), 929–935 (2004).
  • Sills GJ , MohanrajR, ButlerE et al.: Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.Epilepsia46(5), 643–647 (2005).
  • Yamauchi A , IeiriI, KataokaY et al.: Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene.Transplantation74(4), 571–572 (2002).
  • van den Heuvel-Eibrink MM , WiemerEA, de Boevere MJ et al.: MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. Blood97(11), 3605–3611 (2001).
  • Meissner K , JedlitschkyG, Meyer zu Schwabedissen H et al.: Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms. Pharmacogenetics14(6), 381–385 (2004).
  • Kurata Y , IeiriI, KimuraM et al.: Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein.Clin. Pharmacol. Ther.72(2), 209–219 (2002).
  • Horinouchi M , SakaedaT, NakamuraT et al.: Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin. Pharm. Res.19(10), 1581–1585 (2002).
  • Moriya Y , NakamuraT, HorinouchiM et al.: Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects. Biol. Pharm. Bull.25(10), 1356–1359 (2002).
  • Tang K , NgoiSM, GweePC et al.: Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations.Pharmacogenetics12(6), 437–450 (2002).
  • Tanabe M , IeiriI, NagataN et al.: Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.J. Pharmacol. Exp. Ther.297(3), 1137–1143 (2001).
  • Furuno T , LandiMT, CeroniM et al.: Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.Pharmacogenetics12(7), 529–534 (2002).
  • Markova S , NakamuraT, SakaedaT et al.: Genotype-dependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation.Drug Metab. Pharmacokinet.21(3), 194–200 (2006).
  • Kimchi-Sarfaty C , OhJM, KimIW et al.: A silent polymorphism in the MDR1gene changes substrate specificity.Science (2007) (In press).
  • Sinues B , FanloA, BernalML et al.: MDR1 C3435T genetic polymorphism and tobacco-related lung cancer.Oncology64(2), 183–185 (2003).
  • Siegsmund M , BrinkmannU, SchaffelerE et al.: Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors.J. Am. Soc. Nephrol.13(7), 1847–1854 (2002).
  • Jamroziak K , MlynarskiW, BalcerczakE et al.: Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur. J. Haematol.72(5), 314–321 (2004).
  • Niell BL , LongJC, RennertG, GruberSB: Genetic anthropology of the colorectal cancer-susceptibility allele APC I1307K: evidence of genetic drift within the Ashkenazim.Am. J. Hum. Genet.73(6), 1250–1260 (2003).
  • Kronn D , JansenV, OstrerH: Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, NY, USA.Arch. Intern. Med.158(7), 777–781 (1998).
  • Pier GB , GroutM, ZaidiT et al.: Salmonella typhi uses CFTR to enter intestinal epithelial cells.Nature393(6680), 79–82 (1998).
  • Gabriel SE , BrigmanKN, KollerBH, BoucherRC, StuttsMJ: Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model.Science266(5182), 107–109 (1994).
  • Ameyaw MM , RegateiroF, LiT et al.: MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.Pharmacogenetics11(3), 217–221 (2001).
  • Li Y , WangY, SunJ, LiY, YangL: Distribution of the functional MDR1 C3435T polymorphism in the Han population of China.Swiss Med. Wkly136(23–24), 377–382 (2006).

Websites

  • National Center for Biotechnological Information (NCBI) SNP database. www.ncbi.nlm.nih.gov/projects/SNP
  • Tel-Aviv University National Laboratory for the Genetics of Israeli Populations homepage. http://nlgip.tau.ac.il
  • New England Biolabs® Inc. NEBcutter V2.0 information page. http://tools.neb.com/NEBcutter2/index. php
  • University of California, Santa Cruz, Genome Bioinformatics homepage. http://genome.ucsc.edu

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.